This page is an English translation of the Korean original. If there is any discrepancy, the Korean version prevails.
| Item | Details |
|---|---|
| A. Classification codes | ICD-10: Q91.2 | Special Copayment Reduction: V160 | Re-certification cycle: 5 years |
| B. Synonyms | None |
| C. Adult onset | Adult onset none — The translocation form, like the complete form, presents with multiple malformations around birth, and survival to adulthood is very rare. However, identifying parental balanced translocation carriers is important in adult genetics. |
| 1. History | The translocation form was described along with the establishment of the subtype classification of Edwards syndrome. Possibility of familial occurrence recognized. |
| 2. Causes | Trisomy of chromosome 18 due to Robertsonian or reciprocal translocation between chromosome 18 and another chromosome. |
| 3. Genetics | 46 chromosomes but 3 copies of chromosome 18 material. Recurrence risk markedly increased when a parent is a balanced translocation carrier. |
| 4. General epidemiology | About 1–2% of Edwards syndrome. High recurrence risk in familial translocation carriers. Rare subtype. |
| 5. Pathophysiology | Unbalanced segregation in gametes of balanced translocation carriers → offspring with 3 copies of chromosome 18 material. |
| 6. Symptoms | Clinical picture similar to the complete form. Multiple congenital malformations, cardiac malformations, developmental delay. |
| 7. Signs | Same spectrum of physical signs as the complete form. No signs specific to the translocation form. |
| 8. Screening | Serum screening and NIPT detect it similarly to the complete form. Active screening recommended for families of balanced translocation carriers. |
| 9. Diagnosis | Translocation confirmed by standard karyotype analysis. Parental karyotype analysis essential. FISH and CMA as adjuncts. |
| 10. Treatment | Same multidisciplinary supportive care as the complete form. No fundamental treatment. |
| 11. Prognosis | Poor, similar to the complete form. Parental genetic counseling is a key element of prognosis management. |
| 12. Prevention | When a parental balanced translocation is identified, recurrence can be prevented by PGT-T or prenatal diagnosis. |
| 13. References | Edwards JH (1960) and 9 others. |
The trisomy 18 translocation form (translocation trisomy 18, Q91.2) is the rarest of the three cytogenetic subtypes of Edwards syndrome. After the complete form (meiotic nondisjunction, Q91.0) was first described in 1960, as karyotyping technology advanced, cases began to be identified in some patients with Edwards syndrome in which, although the total chromosome number is 46, chromosome 18 material is attached to (translocated onto) another chromosome and present in three copies.
With the introduction of chromosome banding techniques in the 1960s and 1970s, cytogenetic classification of the translocation form became possible. Unlike the trisomy 13 translocation form, in which Robertsonian translocation is common, in the trisomy 18 translocation form both reciprocal translocation and Robertsonian translocation are rarely reported. Chromosome 18 is a non-acrocentric chromosome and therefore not a target of Robertsonian translocation, but a translocation form can arise from structural rearrangement.
The clinical importance of the translocation form lies in the possibility of familial occurrence. When one parent is a carrier of a balanced translocation, there is a probability that an unbalanced chromosome combination (unbalanced karyotype) is generated during meiosis, so there is a risk of recurrence of Edwards syndrome. For this reason, when the translocation form is diagnosed, parental karyotype analysis is always included in standard care.
The proportion of the translocation form in trisomy 13 (about 10%) is much higher than that in trisomy 18 (about 1–2%). This is because chromosome 13 is an acrocentric chromosome and thus easily becomes a target of Robertsonian translocation. Chromosome 18 is a medium-sized submetacentric chromosome and is not a direct target of Robertsonian translocation; even when the translocation form occurs, it is rare, and combinations with various translocation partners are reported.
Since the 2000s, advances in chromosomal microarray technology have made detailed structural analysis of the translocation form possible. In particular, additional genomic imbalances can now be detected in complex rearrangements, which has improved understanding of the phenotypic diversity of the translocation form. Although translocation Edwards syndrome is a rare occurrence, it should be recognized as a diagnosis that plays a key role in preventing familial occurrence.
The trisomy 18 translocation form (Q91.2) is a structural chromosomal abnormality in which all or part of chromosome 18 is translocated with another chromosome, so that chromosome 18 genetic material is present in three copies (triplication). The total chromosome number is 46, or may differ depending on the type of translocation.
Reciprocal translocation: A translocation in which breakage and rejoining occur between two non-homologous chromosomes so that they exchange segments. When a parent is a balanced reciprocal translocation carrier involving chromosome 18, if the translocation chromosomes and normal chromosomes segregate during meiosis by 3:1 malsegregation or unbalanced 2:2 segregation, unbalanced offspring with an excess of chromosome 18 material may arise.
Robertsonian translocation: Robertsonian translocation is a translocation in which, after loss of the short arms of two acrocentric chromosomes (chromosomes 13, 14, 15, 21, 22), the long arms fuse. Because chromosome 18 is non-acrocentric, it is not a direct target of classical Robertsonian translocation, but very rarely there are reports of cases in which chromosome 18 material is inserted into the long arm of an acrocentric chromosome, or structural rearrangement of chromosome 18 itself results in a similar phenotype.
Insertional translocation: Insertion of a segment of one chromosome into another chromosome can also generate an additional copy of chromosome 18 material. Such atypical translocations may not be detected on standard G-banding karyotype analysis, so microarray or FISH analysis is needed.
De novo translocation: This is the case in which a new translocation has arisen even though the parental karyotypes are normal. In this case the recurrence risk is low, but familial and sporadic cases must be distinguished by parental karyotype analysis. In familial cases, counseling about recurrence risk is key to prevention.
The genetic feature of the trisomy 18 translocation form is the pattern in which unbalanced offspring arise from parents who are balanced translocation carriers. This is the most different point from the complete or mosaic forms and is of key significance for prevention.
Risk to offspring of balanced translocation carrier parents: When one parent is a balanced translocation carrier involving chromosome 18, various offspring are generated during meiosis depending on the segregation pattern of the translocation chromosomes. Theoretically, offspring with a normal karyotype, offspring who are balanced translocation carriers, and unbalanced offspring (Edwards syndrome phenotype) can be generated. The actual risk differs by the type of translocation, the translocation partner chromosome, and the parent's sex. The empirical recurrence risk tends to be higher when the balanced translocation carrier parent is the mother than when it is the father (maternal transmission bias).
Karyotype notation: The karyotype of translocation Edwards syndrome is written in various ways depending on the nature of the translocation. For example, in the case of reciprocal translocation it is written in the form 46,XX,der(X)t(X;18)(p22;q11),+18, and in the case of insertional translocation as 46,XX,ins(x;18), etc. Accurate karyotype notation is essential for analysis of recombination and segregation patterns.
Size of the unbalanced region and phenotype: Depending on the size of the excess chromosome 18 material due to the translocation and the genes it contains, there may be diversity in phenotype. When all of chromosome 18 is trisomic, the Edwards syndrome phenotype is the same as the complete form, and when it is partial trisomy 18, the phenotype may differ. Therefore, precisely defining the unbalanced region by CMA helps in diagnosis and in analysis of phenotype-genotype correlation.
Recurrence risk counseling is the most important element of genetic counseling when translocation Edwards syndrome is diagnosed. Depending on the parental karyotype analysis results, carrier testing for siblings and relatives and a prenatal diagnosis plan should be established. Even in sporadic translocations the recurrence risk is not completely absent, so it is standard to recommend prenatal diagnosis in the next pregnancy.
The trisomy 18 translocation form (Q91.2) accounts for about 1–2% of all Edwards syndrome and is the rarest of the three subtypes. Compared with the complete form (about 95%) and the mosaic form (about 2–5%), the translocation form accounts for an extremely small number. The absolute incidence per live birth is very low, making accurate statistics difficult to obtain.
The epidemiological characteristic of the translocation form differs from the complete and mosaic forms in that familial occurrence is possible. When one parent is a balanced translocation carrier, there is a theoretical risk in each pregnancy of having a child with Edwards syndrome, and this risk may differ greatly depending on the type of translocation. The empirical recurrence risk in translocation carrier parents is often not quantified as precisely as in the translocation form of Down syndrome (Robertsonian translocation between chromosome 14 or 21).
Correlation with maternal age: Unlike advanced maternal age being a risk factor in the complete meiotic nondisjunction form, the translocation form, in familial cases arising from balanced translocation carriers, occurs regardless of maternal age. In de novo translocation forms there may be some correlation with maternal age, but because the translocation form is rare, it is difficult to reach a statistically clear conclusion.
In Korea, cases of translocation Edwards syndrome are reported extremely rarely. When the translocation form is diagnosed, balanced translocation carrier testing of parents and relatives is important, through which a prenatal diagnosis plan for other pregnancies in the family can be established. The possibility that children with Edwards syndrome include the translocation form should always be considered, taking care not to miss a translocation on karyotype analysis.
The reason translocation Edwards syndrome is less recognized than the complete or mosaic forms is that its incidence is low and accurately describing the translocation structure on karyotype analysis can be technically difficult. In complex translocation structures, standard G-banding analysis alone makes it difficult to define the translocation partner chromosome and the exact breakpoints, so supplementation with FISH or CMA is needed.
The pathophysiology of the trisomy 18 translocation form is unbalanced segregation of translocation chromosomes occurring in the gametes of parents who are balanced translocation carriers. That is, translocation chromosomes and normal chromosomes do not segregate correctly during meiosis, and gametes with an excess of chromosome 18 material are formed.
In parents who are carriers of a balanced reciprocal translocation, the translocation chromosomes and the normal homologous chromosomes form a quadrivalent in meiosis I. Depending on how this quadrivalent segregates, six or more gamete combinations can be generated. (1) Alternate segregation: generates offspring with a normal karyotype or balanced translocation carrier offspring. (2) Adjacent segregation (adjacent-1, adjacent-2 segregation): generates offspring with unbalanced karyotypes (including Edwards syndrome). (3) 3:1 malsegregation: 3 of the quadrivalent segregate to one daughter cell and 1 to the other, generating unbalanced offspring.
In practice, the frequency of unbalanced offspring in balanced translocation carrier parents differs greatly depending on the type of translocation, the location of the breakpoints, and the size of the unbalanced region. The larger the unbalanced region, the more nonviable offspring there are, and the higher the frequency of miscarriage. Unbalanced offspring involving all of chromosome 18 show the Edwards syndrome phenotype and mostly miscarry spontaneously during pregnancy or die immediately after birth.
In the case of de novo translocation: new chromosomal breakage and rejoining occur at the stage of gamete formation or early division of the zygote, resulting in an excess of chromosome 18 material. In this case the parental karyotypes are normal and the recurrence risk is very low but not zero.
In translocation Edwards syndrome, the phenotype is determined by the amount of excess chromosome 18 material and which genes are present in three copies. If all of chromosome 18 is trisomic, the phenotype is the same as complete Edwards syndrome, and if partially trisomic, a different phenotype may appear depending on the chromosomal region involved. This is why precise analysis of the unbalanced region by CMA is important for understanding phenotype-genotype correlation.
The clinical symptoms of translocation trisomy 18 (Q91.2) are basically the same as those of complete Edwards syndrome (Q91.0). When all of chromosome 18 is present in three copies, the same multiple congenital malformations and severe developmental delay as in the complete form appear.
Cardiovascular malformations: Congenital heart defects are the most common and important malformations, and ventricular septal defect (VSD), patent ductus arteriosus (PDA), atrial septal defect (ASD), polyvalvular disease, and double outlet right ventricle (DORV) occur. The type and severity of cardiac malformations may differ between individuals.
Nervous system malformations and developmental delay: Structural brain malformations such as microcephaly, agenesis of the corpus callosum, cerebellar hypoplasia, and Dandy-Walker malformation, along with severe intellectual disability and developmental delay, appear. Intellectual disability is present in all surviving children.
Skeletal and limb malformations: The characteristic overlapping hand posture (overlapping fingers), brachydactyly, rocker-bottom feet or clubfoot, a short sternum, and limb shortening are observed. These limb findings appear identically in the complete and translocation forms.
Gastrointestinal and genitourinary malformations: Esophageal atresia, intestinal malformations, renal malformations, and bladder malformations may accompany.
Respiratory problems: Respiratory failure, apnea, and aspiration risk are problems from the neonatal period.
In the case of partial trisomy: When only part of chromosome 18 is present in three copies due to the translocation, the phenotype may differ from the complete form. In this case, it may be more appropriate to describe it as 'partial trisomy 18' or 'duplication 18'. The phenotype of partial trisomy varies widely depending on the gene content of the chromosomal segment involved and may differ from the typical phenotype of Edwards syndrome.
The physical signs of translocation Edwards syndrome are basically the same as those of the complete form. Confirming the translocation on karyotype analysis is the only distinctive feature added to the clinical diagnosis. The translocation form cannot be distinguished from the complete or mosaic forms by physical examination findings alone.
Craniofacial signs: Microcephaly, prominent occiput, small face, low-set ears, short sternum, microphthalmia, short palpebral fissures, and high arched palate are observed.
Limb signs: Characteristic overlapping fingers (index finger over middle finger, little finger over ring finger), rocker-bottom feet or clubfoot deformity, brachydactyly, and limb shortening appear.
Cardiac signs: A heart murmur on auscultation, cyanosis, and signs of heart failure (tachypnea, hepatomegaly, edema) may appear.
Physique and muscle tone signs: Low birth weight, decreased skin tension, hypotonia or spasticity, and weak sucking reflex appear.
Prenatal ultrasound findings: The translocation form shows the same prenatal ultrasound findings as the complete form (choroid plexus cysts, cardiac malformations, growth retardation, characteristic hand posture, rocker-bottom feet, etc.). When these findings are found prenatally and karyotype analysis is performed, this becomes a pathway by which the translocation form is discovered. NIPT, as with the complete form, detects the trisomy 18 signal, so detection of the translocation form is possible, but even if the NIPT result is positive, invasive karyotype analysis is essential to distinguish the complete form from the translocation form.
Karyotype findings: On standard G-banding karyotype analysis, the total chromosome number is 46, but one chromosome is observed to be abnormally large or structurally abnormal. Various forms of structural abnormality are observed depending on the nature of the translocation chromosome. Additional FISH or CMA testing is needed to define the exact translocation structure.
Prenatal screening for translocation Edwards syndrome is performed by methods similar to the complete form. However, there are important considerations specific to the translocation form.
Maternal serum screening (MSS) and first-trimester screening: In the translocation form as well, because chromosome 18 material is trisomic, a pattern of abnormal serum markers similar to the complete form (AFP↓, uE3↓, hCG↓, inhibin A↓) appears. Increased fetal nuchal translucency (NT) may also be observed. Therefore, the translocation form can also be detected on standard serum screening.
NIPT (cfDNA): Because NIPT works on the principle of detecting an excess of chromosome 18 material, it can detect an excess chromosome 18 signal in the translocation form as well. However, by the nature of the translocation, the translocated chromosome 18 segment is attached to another chromosome, so NIPT results may appear somewhat atypical. A positive NIPT result must be confirmed by karyotype analysis, and the complete, mosaic, and translocation forms must be distinguished.
Prenatal ultrasound: The same abnormal ultrasound findings as in the complete form may be observed. When ultrasound abnormalities are found, invasive karyotype analysis is performed.
Screening of families of balanced translocation carriers: When, after a diagnosis of translocation Edwards syndrome in a previous pregnancy, parental karyotype analysis identifies a balanced translocation carrier, prenatal karyotype analysis must be performed in the next pregnancy, and carrier screening of siblings and family is recommended. This is the most important feature that distinguishes screening for translocation Edwards syndrome from the complete form.
After birth: In newborns showing clinical findings of Edwards syndrome, karyotype analysis also confirms whether it is the translocation form. If diagnosed as the translocation form, parental karyotype analysis is performed immediately.
The key to diagnosing translocation trisomy 18 is to confirm the translocation structure by standard karyotype analysis and to always perform parental karyotype analysis.
Standard G-banding karyotype analysis: High-resolution G-banding karyotype analysis is performed on peripheral blood lymphocytes. In the translocation form, the total chromosome number is 46 (or varies in some cases), and chromosome 18 and the translocation partner chromosome are observed in abnormal forms. When a translocation structure is found on karyotype analysis, additional testing is needed to define the exact breakpoints.
FISH: Using probes specific to chromosome 18 and the translocation partner chromosome, the translocation structure is visually confirmed and the copy number of chromosome 18 material is accurately determined. It is very useful for confirming the translocation form.
Chromosomal microarray (CMA): SNP array or CGH array precisely defines the chromosome 18 trisomic region and detects additional genomic imbalances (deletions or duplications). It is essential for accurately identifying the unbalanced region in partial trisomy. Array analysis is also important for phenotype-genotype correlation analysis.
Parental karyotype analysis: G-banding karyotype analysis of peripheral blood is performed on both parents of a child diagnosed with the translocation form. This is an absolutely necessary step in the diagnosis of translocation Edwards syndrome. When a balanced translocation carrier is found in one parent, recurrence risk counseling and extended family screening are performed.
Prenatal diagnosis: In the next pregnancy of parents who are balanced translocation carriers, karyotype analysis, FISH, and CMA are performed after CVS or amniocentesis to determine whether Edwards syndrome is present. It is also possible to prevent implantation of unbalanced embryos from translocation carrier parents through preimplantation genetic testing (PGT-SR/PGT-T).
As with the complete form, treatment of translocation Edwards syndrome cannot correct the underlying chromosomal abnormality, so it is based on multidisciplinary supportive care.
Neonatal intensive care: Immediately after birth, cardiopulmonary stabilization, nutritional support, and infection prevention are provided in the neonatal intensive care unit (NICU). The use of supplemental oxygen, mechanical ventilation, and vasoactive agents is individualized according to the clinical condition and the family's wishes.
Treatment of cardiac malformations: With the same structure of discussion as the complete form, the indications for cardiac surgery are decided by the multidisciplinary team together with the family. Because cardiac malformations are a major cause of death in Edwards syndrome in the translocation form as well, neurological prognosis and overall life expectancy are considered together when deciding on surgery.
Nutritional support: Nutrition via tube feeding or gastrostomy is needed. Swallowing therapy and an oral stimulation program are combined.
Developmental support: In surviving children, physical therapy, occupational therapy, and speech therapy are started early. Early intervention programs applied to other trisomy syndromes such as Down syndrome are referenced and adapted to suit Edwards syndrome.
Genetic counseling and family support: In the translocation form, recurrence risk counseling according to the parental karyotype results is as important as treatment. Balanced translocation carrier parents are thoroughly informed of future pregnancy planning and PGT-T or prenatal diagnosis options and are given psychological support. Carrier screening and genetic counseling for other members of the family are recommended.
Palliative care and hospice: The palliative care team is involved early to support the family's decision-making and to provide end-of-life planning and psychological, social, and spiritual support.
The survival prognosis of the trisomy 18 translocation form (Q91.2) is poor, similar to the complete form (Q91.0), when all of chromosome 18 is trisomic. The median survival is several days to several weeks, and the 1-year survival rate is estimated at around 5–10%. The main causes of death are heart failure, respiratory failure, apnea, and infection.
In partial trisomy 18, the phenotype is variable, so the prognosis also differs depending on the genes involved and the size of the unbalanced region. In some partial trisomy cases, a milder phenotype and better survival than the complete form are reported. However, clinical judgment is needed on whether it is appropriate to classify these as Edwards syndrome (Q91.2).
Genetic prognosis (familial recurrence risk): The most important prognosis-related information in the translocation form is the familial recurrence risk. When a balanced translocation carrier is identified on parental karyotype analysis, prenatal genetic diagnosis is needed in all subsequent pregnancies, and prevention through PGT-T is possible. It is specifically counseled that in carrier parents the risk of unbalanced offspring in each pregnancy can range from several percent to several tens of percent.
Because recurrence of Edwards syndrome has been reported in siblings of children with the translocation form, prenatal diagnosis is strongly recommended in pregnancies of siblings. When a parental balanced translocation is known in advance, affected embryos can be excluded before implantation through PGT-T.
The most important point in prevention of the trisomy 18 translocation form that differs from the complete or mosaic forms is that active prevention is possible when a parental balanced translocation carrier is identified.
Parental karyotype analysis and carrier identification: When translocation Edwards syndrome is diagnosed, parental karyotype analysis must be performed to determine whether a parent is a balanced translocation carrier. Identifying carriers is the starting point of the prevention strategy for future pregnancies.
Preimplantation genetic testing (PGT-SR/PGT-T): When parents who are balanced translocation carriers undergo assisted reproduction, preimplantation genetic testing for detecting translocation-related imbalance at the embryo stage (PGT-SR: structural rearrangement) can be performed to prevent implantation of affected embryos. This is effective in preventing recurrent miscarriage and the birth of a child with Edwards syndrome.
Prenatal genetic diagnosis: In each pregnancy of carrier parents, the fetal chromosomal status is confirmed by karyotype analysis or CMA via CVS or amniocentesis. When an unbalanced karyotype (Edwards syndrome) is confirmed, whether to continue the pregnancy is decided according to the family's decision.
Extended family screening: Carrier karyotype analysis is recommended for the siblings and other family members of parents who are balanced translocation carriers. In this way, all carriers within the family who are at risk of having a child with Edwards syndrome are identified early and prenatal diagnosis plans are established.
Genetic counseling: Families with translocation Edwards syndrome are provided with structured genetic counseling that thoroughly explains the mechanism of translocation, the meaning of being a carrier, the recurrence risk, prenatal diagnosis options, and the possibility of PGT-T. In this process, psychological support and ethical considerations should also be addressed.